WAM
ABBV icon

WFA Asset Management’s AbbVie ABBV Stock Holding History

WFA Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$1.38M Buy
7,003
+55
+0.8% +$11.2K 0.75% 18
2025
Q2 		$1.19M Buy
6,948
+64
+0.9% +$11.9K 0.67% 18
2025
Q1 		$1.25M Sell
6,884
-130
-2% -$25.3K 0.66% 17
2024
Q4 		$1.25M Buy
7,014
+11
+0.2% +$2.02K 0.67% 18
2024
Q3 		$1.38M Buy
7,003
+55
+0.8% +$10.3K 0.75% 18
2024
Q2 		$1.19M Buy
6,948
+64
+0.9% +$10.6K 0.67% 18
2024
Q1 		$1.25M Sell
6,884
-16
-0.2% -$2.76K 0.66% 17
2023
Q4 		$1.07M Buy
6,900
+73
+1% +$10.6K 0.58% 18
2023
Q3 		$1.02M Buy
6,827
+80
+1% +$11.7K 0.6% 18
2023
Q2 		$909K Sell
6,747
-29
-0.4% -$4.25K 0.54% 20
2023
Q1 		$1.08M Buy
6,776
+66
+1% +$10.1K 0.66% 17
2022
Q4 		$1.08M Buy
6,710
+60
+0.9% +$9.2K 0.71% 18
2022
Q3 		$892K Buy
6,650
+139
+2% +$19.9K 0.64% 16
2022
Q2 		$997K Buy
6,511
+208
+3% +$31.8K 0.7% 15
2022
Q1 		$1.02M Sell
6,303
-42
-0.7% -$6.1K 0.67% 15
2021
Q4 		$859K Buy
+6,345
New +$750K 0.56% 14

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

WFA Asset Management's ABBV Position: Q3 2025 in Review

WFA Asset Management increased its AbbVie (ABBV) stake by 0.79% in Q3 2025, buying an estimated $11.2K and bringing the position to 7,003 shares worth $1.38M. The position accounts for 0.75% of the portfolio, ranked #18.

WFA Asset Management first reported a position in ABBV in Q4 2021 and has held it in 16 quarters since. 3,905 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

  • WFA Asset Management held 7,003 shares of AbbVie worth $1.38M as of Q3 2025.
  • WFA Asset Management bought 55 AbbVie shares in Q3 2025, an estimated $11.2K.
  • AbbVie made up 0.75% of WFA Asset Management's portfolio in Q3 2025, its #18 holding.
  • WFA Asset Management first reported a position in AbbVie in Q4 2021 and has held it in 16 quarters since.
  • 3,905 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on WFA Asset Management's 13F filing for Q3 2025, filed 30 Oct 2025.